Alaunos Therapeutics (FRA:WEK) Other Long-Term Liabilities : €0.00 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Alaunos Therapeutics Other Long-Term Liabilities?

Alaunos Therapeutics's other long-term liabilities for the quarter that ended in Dec. 2023 was €0.00 Mil.

Alaunos Therapeutics's quarterly other long-term liabilities increased from Jun. 2023 (€-0.00 Mil) to Sep. 2023 (€-0.00 Mil) and increased from Sep. 2023 (€-0.00 Mil) to Dec. 2023 (€0.00 Mil).

Alaunos Therapeutics's annual other long-term liabilities increased from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€0.03 Mil) but then declined from Dec. 2022 (€0.03 Mil) to Dec. 2023 (€0.00 Mil).

Alaunos Therapeutics Other Long-Term Liabilities Historical Data

The historical data trend for Alaunos Therapeutics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alaunos Therapeutics Other Long-Term Liabilities Chart

Alaunos Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Alaunos Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Alaunos Therapeutics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Alaunos Therapeutics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Alaunos Therapeutics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Alaunos Therapeutics (FRA:WEK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alaunos Therapeutics Inc (FRA:WEK) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

TCRT:USA

Address

8030 El Rio Street, Houston, TX, USA, 77054

Website

https://www.alaunos.com

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations.

Alaunos Therapeutics (FRA:WEK) Headlines

No Headlines